Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 6969040, 5 pages
http://dx.doi.org/10.1155/2016/6969040
Review Article

Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes

Department of Physiology, College of Medicine, University of Dammam, P. O. Box 2114-31451, Dammam, Saudi Arabia

Received 17 July 2016; Accepted 15 September 2016

Academic Editor: Ilias Migdalis

Copyright © 2016 Mohammed Al-Hariri. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. T. Dauphine, B. L. Riggs, and D. A. Scholz, “Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism,” Annals of Internal Medicine, vol. 83, no. 3, pp. 365–367, 1975. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes,” Calcified Tissue International, vol. 84, no. 1, pp. 45–55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. N. Farr and S. Khosla, “Determinants of bone strength and quality in diabetes mellitus in humans,” Bone, vol. 82, pp. 28–34, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Janghorbani, R. M. Van Dam, W. C. Willett, and F. B. Hu, “Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture,” American Journal of Epidemiology, vol. 166, no. 5, pp. 495–505, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Vestergaard, “Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis,” Osteoporosis International, vol. 18, no. 4, pp. 427–444, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. N. Pramojanee, M. Phimphilai, N. Chattipakorn, and S. C. Chattipakorn, “Possible roles of insulin signaling in osteoblasts,” Endocrine Research, vol. 39, no. 4, pp. 144–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Adami, “Bone health in diabetes: considerations for clinical management,” Current Medical Research and Opinion, vol. 25, no. 5, pp. 1057–1072, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Nelson and S. J. Jacober, “Why do older women with diabetes have an increased fracture risk?” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 1, pp. 29–31, 2001. View at Google Scholar
  9. P.-J. López-Ibarra, M. M. C. Pastor, F. Escobar-Jiménez et al., “Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus,” Endocrine Practice, vol. 7, no. 5, pp. 346–351, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Piepkorn, P. Kann, T. Forst, J. Andreas, A. Pfützner, and J. Beyer, “Bone mineral density and bone metabolism in diabetes mellitus,” Hormone and Metabolic Research, vol. 29, no. 11, pp. 584–591, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. M. E. Garay-Sevilla, L. E. Nava, J. M. Malacara, K. Wróbel, K. Wróbel, and U. Pérez, “Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with Type 2 diabetes mellitus,” Diabetes/Metabolism Research and Reviews, vol. 16, no. 2, pp. 106–113, 2000. View at Google Scholar · View at Scopus
  12. H. Tanaka, T. Hamano, N. Fujii et al., “The impact of diabetes mellitus on vitamin D metabolism in predialysis patients,” Bone, vol. 45, no. 5, pp. 949–955, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Ziegler, “Diabetes mellitus and bone metabolism,” Hormone and Metabolic Research, Supplement, vol. 26, pp. 90–94, 1992. View at Google Scholar
  14. F. Lumachi, V. Camozzi, V. Tombolan, and G. Luisetto, “Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus,” Annals of the New York Academy of Sciences, vol. 1173, supplement 1, pp. E64–E67, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Hamada, H. Fujii, R. Kitazawa, J. Yodoi, S. Kitazawa, and M. Fukagawa, “Thioredoxin-1 overexpression in transgenic mice attenuates streptozotocin-induced diabetic osteopenia: a novel role of oxidative stress and therapeutic implications,” Bone, vol. 44, no. 5, pp. 936–941, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Lozano, L. F. de Castro, S. Dapía et al., “Role of parathyroid hormone-related protein in the decreased osteoblast function in diabetes-related osteopenia,” Endocrinology, vol. 150, no. 5, pp. 2027–2035, 2009. View at Google Scholar
  17. B. Basha, D. S. Rao, Z.-H. Han, and A. M. Parfitt, “Osteomalacia due to vitamin D depletion: a neglected consequence of intestinal malabsorption,” The American Journal of Medicine, vol. 108, no. 4, pp. 296–300, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Tahrani, A. Ball, L. Shepherd, A. Rahim, A. F. Jones, and A. Bates, “The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK,” International Journal of Clinical Practice, vol. 64, no. 3, pp. 351–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. D. R. Curran, J. R. McArdle, and J. S. Talwalkar, “Diabetes mellitus and bone disease in cystic fibrosis,” Seminars in Respiratory and Critical Care Medicine, vol. 30, no. 5, pp. 514–530, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. L. Elkin, A. Fairney, S. Burnett et al., “Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study,” Osteoporosis International, vol. 12, no. 5, pp. 366–372, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K. M. Thrailkill, “Diabetes care for adolescents,” in Diabetes in Women: Adolescence, Pregnancy and Menopause, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 3rd edition, 2004. View at Google Scholar
  22. A. M. Parfitt, Z.-H. Han, S. Palnitkar, D. S. Rao, M.-S. Shih, and D. Nelson, “Effects of ethnicity and age or menopause on osteoblast function, bone mineralization, and osteoid accumulation in iliac bone,” Journal of Bone and Mineral Research, vol. 12, no. 11, pp. 1864–1873, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Qiu, S. Palnitkar, and D. S. Rao, “Age-related changes in osteocyte density and distribution in human cancellous bone,” Journal Of Bone & Mineral Research, vol. 14, supplement 1, p. S308, 1999. View at Google Scholar
  24. Y. Takeuchi, “Overview: derangement of bone metabolism in diabetes mellitus,” Clinical Calcium, vol. 19, no. 9, pp. 1247–1255, 2009. View at Google Scholar · View at Scopus
  25. P. Pooruk, N. Kittimanon, P. Janthorn, and N. Bunyaratavej, “The impacts of type 2 diabetes mellitus on bone markers in the elderly Thai women,” Journal of the Medical Association of Thailand, vol. 92, pp. S45–S48, 2009. View at Google Scholar · View at Scopus
  26. T. Thomas, B. Burguera, L. J. Melton III et al., “Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women,” Bone, vol. 29, no. 2, pp. 114–120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. D. T. Felson, Y. Zhang, M. T. Hannan, and J. J. Anderson, “Effects of weight and body mass index on bone mineral density in men and women: the Framingham study,” Journal of Bone and Mineral Research, vol. 8, no. 5, pp. 567–573, 1993. View at Google Scholar · View at Scopus
  28. T. A. Einhorn, A. L. Boskey, C. M. Gundberg, V. J. Vigorita, V. J. Devlin, and M. M. Beyer, “The mineral and mechanical properties of bone in chronic experimental diabetes,” Journal of Orthopaedic Research, vol. 6, no. 3, pp. 317–323, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Verhaeghe, A. M. H. Suiker, B. L. Nyomba et al., “Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis,” Endocrinology, vol. 124, no. 2, pp. 573–582, 1989. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Verhaeghe, W. J. Visser, T. A. Einhorn, and R. Bouillon, “Osteoporosis and diabetes: lessons from the diabetic BB rat,” Hormone Research in Paediatrics, vol. 34, no. 5-6, pp. 245–248, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Verhaeghe, A. M. H. Suiker, W. J. Visser, E. Van Herck, R. Van Bree, and R. Bouillon, “The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats,” Journal of Endocrinology, vol. 134, no. 3, pp. 485–492, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. J. C. Krakauer, M. J. McKenna, N. F. Buderer, D. Sudhaker Rao, F. W. Whitehouse, and A. Michael Parfitt, “Bone loss and bone turnover in diabetes,” Diabetes, vol. 44, no. 7, pp. 775–782, 1995. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Hampson, C. Evans, R. J. Petitt et al., “Bone mineral density, collagen type 1 α 1 genotypes and bone turnover in premenopausal women with diabetes mellitus,” Diabetologia, vol. 41, no. 11, pp. 1314–1320, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Kawashima, J. C. Fritton, S. Yakar et al., “Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis,” Bone, vol. 44, no. 4, pp. 648–655, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. R. G. Paul and A. J. Bailey, “Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes,” International Journal of Biochemistry and Cell Biology, vol. 28, no. 12, pp. 1297–1310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. P. L. Selby, “Osteopenia and diabetes,” Diabetic Medicine, vol. 5, no. 5, pp. 423–428, 1988. View at Publisher · View at Google Scholar · View at Scopus
  37. P. McNair, C. Christiansen, M. S. Christensen et al., “Development of bone mineral loss in insulin-treated diabetes: a 1 1/2 years follow-up study in sixty patients,” European Journal of Clinical Investigation, vol. 11, no. 1, pp. 55–59, 1981. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Seino and H. Ishida, “Diabetic osteopenia: pathophysiology and clinical aspects,” Diabetes/Metabolism Reviews, vol. 11, no. 1, pp. 21–35, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Ishida, Y. Seino, T. Taminato et al., “Circulating levels and bone contents of bone γ-carboxyglutamic acid-containing protein are decreased in streptozocin-induced diabetes: possible marker for diabetic osteopenia,” Diabetes, vol. 37, no. 6, pp. 702–706, 1988. View at Publisher · View at Google Scholar · View at Scopus
  40. A. B. Anwana and H. O. Garland, “Renal calcium and magnesium handling in experimental diabetes mellitus in the rat,” Acta Endocrinologica, vol. 122, no. 4, pp. 479–486, 1990. View at Google Scholar · View at Scopus
  41. R. T. Loder, “The influence of diabetes mellitus on the healing of closed fractures,” Clinical Orthopaedics and Related Research, no. 232, pp. 210–216, 1988. View at Google Scholar · View at Scopus
  42. L. Cozen, “Does diabetes delay fracture healing?” Clinical Orthopaedics and Related Research, vol. 82, pp. 134–140, 1972. View at Google Scholar · View at Scopus
  43. W. A. Tyndall, H. A. Beam, C. Zarro, J. P. O'Connor, and S. S. Lin, “Decreased platelet derived growth factor expression during fracture healing in diabetic animals,” Clinical Orthopaedics and Related Research, vol. 408, pp. 319–330, 2003. View at Google Scholar · View at Scopus
  44. A. Gandhi, C. Dumas, J. P. O'Connor, J. R. Parsons, and S. S. Lin, “The effects of local platelet rich plasma delivery on diabetic fracture healing,” Bone, vol. 38, no. 4, pp. 540–546, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. H. L. Gooch, J. E. Hale, H. Fujioka, G. Balian, and S. R. Hurwitz, “Alterations of cartilage and collagen expression during fracture healing in experimental diabetes,” Connective Tissue Research, vol. 41, no. 2, pp. 81–91, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Wallace, G. E. Reiber, J. LeMaster et al., “Incidence of falls, risk factors for falls, and fall-related fractures in individuals with diabetes and a prior foot ulcer,” Diabetes Care, vol. 25, no. 11, pp. 1983–1986, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. S. S. Johnston, C. Conner, M. Aagren, K. Ruiz, and J. Bouchard, “Association between hypoglycaemic events and fall-related fractures in Medicare-covered patients with type 2 diabetes,” Diabetes, Obesity and Metabolism, vol. 14, no. 7, pp. 634–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. “Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial,” The Journal of the American Medical Association, vol. 276, no. 17, pp. 1409–1415, 1996. View at Publisher · View at Google Scholar
  49. M. M. Campos Pastor, P. J. López-Ibarra, F. Escobar-Jiménez, M. D. Serrano Pardo, and A. García-Cervigón, “Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study,” Osteoporosis International, vol. 11, no. 5, pp. 455–459, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. P. R. Cavanagh, J. A. Derr, J. S. Ulbrecht, R. E. Maser, and T. J. Orchard, “Problems with gait and posture in neuropathic patients with insulin-dependent diabetes mellitus,” Diabetic Medicine, vol. 9, no. 5, pp. 469–474, 1992. View at Publisher · View at Google Scholar · View at Scopus
  51. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, no. 3, pp. 266–281, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Bilik, L. N. McEwen, M. B. Brown et al., “Thiazolidinediones and fractures: evidence from translating research into action for diabetes,” The Journal of Clinical Endocrinology & Metabolism, vol. 95, no. 10, pp. 4560–4565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Are antiresorptive drugs effective against fractures in patients with diabetes?” Calcified Tissue International, vol. 88, no. 3, pp. 209–214, 2011. View at Publisher · View at Google Scholar · View at Scopus